NCT03977805View on ClinicalTrials.gov

Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 25, 2019

Primary Completion Date

June 13, 2019

Study Completion Date

June 13, 2019

Conditions
Healthy
Interventions
DRUG

Hetrombopag Olamine

a single oral taking

Trial Locations (1)

Unknown

The first affiliated hospital of Suzhou university, Suzhou

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT03977805 - Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects | Biotech Hunter | Biotech Hunter